Although the mutations and oncogenic potential of HCAR3 in some types of cancer might be disturbing, individuals with melanoma exhibit markedly lower levels of HCAR3 gene expression relative to healthy skin samples, according to GEPIA2 database results. This evidence concerns the gene HCAR3 and cancer.